• Home
  • Advanced Search
  • Directory of Libraries
  • About lib.ir
  • Contact Us
  • History

عنوان
A possible role for dupilumab (Dupixent) in the management of idiopathic chronic eczematous eruption of aging

پدید آورنده
Brummer, Grace C; Wang, Lawrence T; Sontheimer, Richard D,Brummer, Grace C; Wang, Lawrence T; Sontheimer, Richard D

موضوع

رده

کتابخانه
Center and Library of Islamic Studies in European Languages

محل استقرار
استان: Qom ـ شهر: Qom

Center and Library of Islamic Studies in European Languages

تماس با کتابخانه : 32910706-025

NATIONAL BIBLIOGRAPHY NUMBER

Number
LA55z1f6xh

LANGUAGE OF THE ITEM

.Language of Text, Soundtrack etc
انگلیسی

TITLE AND STATEMENT OF RESPONSIBILITY

Title Proper
A possible role for dupilumab (Dupixent) in the management of idiopathic chronic eczematous eruption of aging
General Material Designation
[Article]
First Statement of Responsibility
Brummer, Grace C; Wang, Lawrence T; Sontheimer, Richard D

SUMMARY OR ABSTRACT

Text of Note
Aging individuals can develop generalized, exquisitely-pruritic, eczematous eruptions of uncertain etiology that can be therapeutically-refractory and life-altering. Limited information exists in the literature to guide clinicians in the diagnosis and management of such patients. It is suggested that in approximately 40% of such patients a known cause for their chronic pruritic eruptions cannot be identified. In this report we will refer to this subgroup of patients as having idiopathic chronic eczematous eruption of aging (CEEA). Idiopathic CEEA must be distinguished from other established eczematous dermatoses. Idiopathic CEEA patients often require long-term systemic immunosuppressive drugs to make living bearable. Elder-onset atopic dermatitis is the most difficult of the known dermatoses to distinguish from idiopathic CEEA. Because of their clinical similarities we questioned whether dupilumab (Dupixent®), the first FDA-approved biologic for atopic dermatitis, might be valuable in the management of idiopathic CEEA. We report the case of an elderly man with idiopathic CEEA of four-years' duration who had a complete clinical response to the initiation of treatment with dupilumab. This case is presented to stimulate more discussion and systematic study of a possible role for dupilumab in otherwise-refractory idiopathic CEEA patients. We also propose a set of diagnostic criteria for idiopathic CEEA.

SET

Date of Publication
2018
Title
Dermatology Online Journal
Volume Number
24/2

PERSONAL NAME - PRIMARY RESPONSIBILITY

Entry Element
Brummer, Grace C; Wang, Lawrence T; Sontheimer, Richard D

ELECTRONIC LOCATION AND ACCESS

Electronic name
 مطالعه متن کتاب 

[Article]
275578

a
Y

Proposal/Bug Report

Warning! Enter The Information Carefully
Send Cancel
This website is managed by Dar Al-Hadith Scientific-Cultural Institute and Computer Research Center of Islamic Sciences (also known as Noor)
Libraries are responsible for the validity of information, and the spiritual rights of information are reserved for them
Best Searcher - The 5th Digital Media Festival